MYC and cancer: In cancer cell lines overexpressing c-MYC, these compounds downregulated c-MYC expression, upregulated tumor suppressor genes (KLF4 and p53), induced DNA damage, apoptosis, and cell-cycle arrest in the G0–G1 phase.